ADDAX Biosciences developed GAF, an innovative histological fixative that works as a substitute to Formalin (recognized as carcinogenic by European Regulation)
A remarkable study on alternative protocols of tissue fixation has shown that GAF® is the only non-carcinogenic option that overcomes the artifacts and low DNA preservation observed in formalin fixation
https://t.co/2xOqqqA8Im
ADDAX parteciperà al 75° Convegno SISVET Società Italiana Scienze Veterinarie. Saremo lieti di poter divulgare l’efficacia di GAF® e proporre l’alternativa alla Formalina che garantisce l’accuratezza delle diagnosi senza esporre il personale veterinario a malattie professionali.
Our latest interview on @BiotecnologieN is now online. Here we tell the story of our company, from the beginning in 2017, until now.
Our main goal is one: free hospitals from the use of toxic formalin and make GAF the main choice for #tissue#fixation!
https://t.co/Uymrq5IZST
📻 Per @RVeronicaOne la nostra Presidente Fiorella Altruda racconta gli obiettivi che abbiamo raggiunto, la nostra mission e come supportiamo chi ha un'idea di impresa a trasformarla in realtà. Per info scriveteci a [email protected]#PLAYTHEONE#JUSTSTART
Our innovative product, #GAF, replaces the use of formalin as fixative. GAF is a non-toxic and non-cancerogenic fixative solution with #histological efficacy. The main goal of GAF is to protect the #health of workers involved in histological #fixation and health of #patients.
In the present paper, researchers from the University of Washington compared the #morphological properties of biological samples fixed with formalin or with #glyoxal. They conclude that glyoxal #fixatives are suitable substitutes for structural and morphological evaluations.
Recently, a group from the university of Georg-August-Universität Göttingen in Germany, demonstrated that #glyoxal can successfully replace formalin, like previously described by our founder prof. Gianni Bussolati in 2017.
Glyoxal was suggested as substitute for formalin in histological fixation for the first time in 1943, here is a chapter of #Science where the efficacy and safety of glyoxal fixation was firstly described.
#glyoxal#research#health#fixation#histology#safety
Bussolati and his collaborators, in 2017, were the first to asses that GAF represents a novel and safe tissue fixative by investigating its reliability in maintaining morphological details and molecular structures of different pathological samples.
https://t.co/qFcS3EauNZ
🌟🏆La start up Addax di 2i3T si aggiudica il Premio IR20 della Regione Piemonte per il progetto "Verso un ospedale senza formalina" con il rivoluzionario fissativo GAF! https://t.co/23B9wkgrS5 https://t.co/3Qx2g9Ltg6 @unito@regionepiemonte#innovazione#startup#ricerca#ir20
🌟🏆La start up Addax di 2i3T si aggiudica il Premio IR20 della Regione Piemonte per il progetto "Verso un ospedale senza formalina" con il rivoluzionario fissativo GAF! https://t.co/23B9wkgrS5 https://t.co/3Qx2g9Ltg6 @unito@regionepiemonte#innovazione#startup#ricerca#ir20